Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

IDkit HP ONE

×

Overview

What is IDkit HP ONE?

The Exalenz BreathID® non-invasive breath test is a diagnostic test that analyzes a breath sample before and after ingestion of C-enriched urea; it is used to identify those patients with infection.The Exalenz BreathID® breath test is performed as follows: a 75 mg C-urea tablet and 4.3 g Citrica Powder are dissolved in water, and the resulting solution is ingested by the patient. The presence of the Citrica creates an acidic environment in the stomach and also delays the transfer of the ingested solution to the duodenum. These two characteristics facilitate the decomposition of the urea by , if present. Thus, in the presence of urease associated with gastric , C-urea is decomposed to CO and NH according to the following equation: 2 C-urea + 2 HO ----------> urease----------> 2 CO+ 2 NH The CO is absorbed into the blood and then exhaled in the breath. Absorption and distribution of CO is fast. Therefore, the cleavage of urea by the urease that produces the CO occurs immediately after the solution is ingested and enables immediate detection of increased CO in the exhaled breath of -positive patients.In the case of -negative patients, the C-urea does not produce CO in the stomach because there are no human enzymes that can decompose the urea in the stomach.



What does IDkit HP ONE look like?



What are the available doses of IDkit HP ONE?

Sorry No records found.

What should I talk to my health care provider before I take IDkit HP ONE?

Sorry No records found

How should I use IDkit HP ONE?

The Exalenz BreathID® Breath Test System is intended for use in the qualitative detection of urease associated with Helicobacter pylori () in the human stomach and as an aid in the initial diagnosis and post treatment monitoring of infection in adult patients. This test should be used after at least four weeks of eradication therapy. For these purposes, the system utilizes Molecular Correlation Spectrometry (MCS™) for the measurement of the ratio of 13CO2 to 12CO2 in breath samples.

The Exalenz BreathID® System is used to detect and monitor infection by measuring changes in the CO to CO ratio in a patient’s breath following the ingestion of C-urea.The Exalenz BreathID® Breath Test System consists of the IDkit: Hp™ kits containing 13C-urea tablet, 75 mg for oral solution and 4.3 g Citrica Powder (4g citric acid) for oral solution; the BreathID® device and the IDcheck™ system quality control accessory.The device is for use by trained healthcare professionals and the test kit is to be administered under a physician’s supervision.


What interacts with IDkit HP ONE?

Sorry No Records found


What are the warnings of IDkit HP ONE?

Sorry No Records found


What are the precautions of IDkit HP ONE?

Sorry No Records found


What are the side effects of IDkit HP ONE?

Sorry No records found


What should I look out for while using IDkit HP ONE?


What might happen if I take too much IDkit HP ONE?

Sorry No Records found


How should I store and handle IDkit HP ONE?

Store at controlled room temperature 15° to 30°C (59° to 86°F).Dispense in tightly-closed, light-resistant container (USP).Store at controlled room temperature 15° to 30°C (59° to 86°F).Dispense in tightly-closed, light-resistant container (USP).This package insert includes information for conducting the BreathID® H. pylori test for two modes of analysis with two Breath Test Kits:The following are trademarks of Exalenz Bioscience Ltd.: Exalenz™ , MCS™, IDcircuit™, IDcheck™,  IDkit: Hp™, and  BreathID®All reference to Exalenz in this document refers to the company Exalenz Bioscience Ltd.Note: This package insert includes information for conducting the BreathID® H. pylori test for two modes of analysis with two Breath Test Kits:The following are trademarks of Exalenz Bioscience Ltd.: Exalenz™ , MCS™, IDcircuit™, IDcheck™,  IDkit: Hp™, and  BreathID®All reference to Exalenz in this document refers to the company Exalenz Bioscience Ltd.Note: This package insert includes information for conducting the BreathID® H. pylori test for two modes of analysis with two Breath Test Kits:The following are trademarks of Exalenz Bioscience Ltd.: Exalenz™ , MCS™, IDcircuit™, IDcheck™,  IDkit: Hp™, and  BreathID®All reference to Exalenz in this document refers to the company Exalenz Bioscience Ltd.Note: This package insert includes information for conducting the BreathID® H. pylori test for two modes of analysis with two Breath Test Kits:The following are trademarks of Exalenz Bioscience Ltd.: Exalenz™ , MCS™, IDcircuit™, IDcheck™,  IDkit: Hp™, and  BreathID®All reference to Exalenz in this document refers to the company Exalenz Bioscience Ltd.Note:


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Non-Clinical Toxicology
Reduced efficacy and increased incidence of breakthrough bleeding and menstrual irregularities have been associated with concomitant use of rifampin. A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, and possibly with griseofulvin, ampicillin and tetracyclines.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).